Literature DB >> 22553107

The importance of anxiety in both major depression and bipolar disorder.

David Goldberg1, Jan Fawcett.   

Abstract

BACKGROUND: Generalized anxiety disorder (GAD) is frequently co-morbid with major depression (MDD), and this becomes more so when the duration requirement is relaxed. Both anxiety diagnoses and anxious symptoms are more common in both unipolar and bipolar depression. This paper explores the relationship between anxious symptoms and GAD with both unipolar and bipolar depression.
METHOD: MDD and bipolar disorder (BPD) are compared in three important respects: the extent of their co-morbidity with anxious symptoms and GAD, the effects that anxiety has on outcome of MDD and BPD, and the effects that anxiety has on the probability of suicide in each disorder.
RESULTS: Anxious diagnoses occur frequently in association with depressive disorders, albeit to a different extent in the various subtypes of depression. In both disorders, anxiety affects the outcome and makes suicidal thoughts, and completed suicide more likely.
CONCLUSIONS: Anxious phenomena should be assessed whenever a depressive disorder is diagnosed. It is likely that the raised expectancy of anxious phenomena is related to an individual's premorbid level of negative affect, and it is possible that suicidal phenomena are related to subthreshold hypomanic symptoms.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22553107     DOI: 10.1002/da.21939

Source DB:  PubMed          Journal:  Depress Anxiety        ISSN: 1091-4269            Impact factor:   6.505


  34 in total

1.  New concepts for ICD-classification of common mental disorders from the perspective of general medical practice.

Authors:  Wolfgang Spiegel; David Goldberg; Christine Princz; Paul Fellinger
Journal:  Wien Med Wochenschr       Date:  2015-08-07

2.  A new method for constructing networks from binary data.

Authors:  Claudia D van Borkulo; Denny Borsboom; Sacha Epskamp; Tessa F Blanken; Lynn Boschloo; Robert A Schoevers; Lourens J Waldorp
Journal:  Sci Rep       Date:  2014-08-01       Impact factor: 4.379

3.  Are official psychiatric classification systems for mental disorders suitable for use in primary care?

Authors:  Sir David Goldberg
Journal:  Br J Gen Pract       Date:  2019-03       Impact factor: 5.386

Review 4.  [Bipolar disorders in DSM-5].

Authors:  E Severus; M Bauer
Journal:  Nervenarzt       Date:  2014-05       Impact factor: 1.214

5.  Anxious depression as a clinically relevant subtype of pediatric major depressive disorder.

Authors:  Isabelle Häberling; Noemi Baumgartner; Sophie Emery; Paola Keller; Michael Strumberger; Kristin Nalani; Klaus Schmeck; Suzanne Erb; Silke Bachmann; Lars Wöckel; Ulrich Müller-Knapp; Brigitte Contin-Waldvogel; Bruno Rhiner; Susanne Walitza; Gregor Berger
Journal:  J Neural Transm (Vienna)       Date:  2019-08-27       Impact factor: 3.575

6.  Intrinsic functional neurocircuitry associated with treatment response to transdiagnostic CBT in bipolar disorder with anxiety.

Authors:  Kristen K Ellard; Aishwarya G Gosai; Emily E Bernstein; Navneet Kaur; Lousia G Sylvia; Joan A Camprodon; Darin D Dougherty; Andrew A Nierenberg; Thilo Deckersbach
Journal:  J Affect Disord       Date:  2018-06-02       Impact factor: 4.839

7.  Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress.

Authors:  Aldemara I Silva; Victor A D Holanda; Joaquim G Azevedo Neto; Edilson D Silva Junior; Vanessa P Soares-Rachetti; Girolamo Calo; Chiara Ruzza; Elaine C Gavioli
Journal:  Psychopharmacology (Berl)       Date:  2020-02-24       Impact factor: 4.530

8.  Do anxiety symptoms predict major depressive disorder in midlife women? The Study of Women's Health Across the Nation (SWAN) Mental Health Study (MHS).

Authors:  H M Kravitz; L L Schott; H Joffe; J M Cyranowski; J T Bromberger
Journal:  Psychol Med       Date:  2014-01-27       Impact factor: 7.723

9.  Depressive Symptoms and Associated Clinical Characteristics in Outpatients Seeking Community-Based Treatment for Alcohol and Drug Problems.

Authors:  Katherine Sanchez; Robrina Walker; Aimee N C Campbell; Tracy L Greer; Mei-Chen Hu; Bruce D Grannemann; Edward V Nunes; Madhukar H Trivedi
Journal:  Subst Abus       Date:  2014-08-01       Impact factor: 3.716

10.  Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety.

Authors:  Elizabeth D Ballard; Dawn F Ionescu; Jennifer L Vande Voort; Mark J Niciu; Erica M Richards; David A Luckenbaugh; Nancy E Brutsché; Rezvan Ameli; Maura L Furey; Carlos A Zarate
Journal:  J Psychiatr Res       Date:  2014-08-12       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.